LD-2 disclosure · 2nd Quarter - Termination
IMMUNE DESIGN
Client
- Name
- IMMUNE DESIGN
- Description
- Development and manufacture of vaccines
- Location
- Washington · United States of America
Registrant
- Description
- government relations
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesDefense
HR 5136 / S 3454, National Defense Authorization Act, 2011, Title II, all provisions relating to development of vaccines for biodefense and infectious diseases.
LobbyistsJESSICA EGGIMANN · JOHN LITTLE · LETITIA WHITE · mr DAVID FREDERICK KILIAN · AMANDA KING
TargetedSENATE · HOUSE OF REPRESENTATIVES
Budget/Appropriations
HR ____, Department of Defense Appropriations Act, 2011, Title IV, all provisions relating to development of vaccines for biodefense and infectious diseases. HR ____, Department of Labor, Health and Human Services Appropriations Act, 2011, Title II, all provisions relating to development of vaccines for infectious diseases.
LobbyistsJESSICA EGGIMANN · JOHN LITTLE · LETITIA WHITE · mr DAVID FREDERICK KILIAN · AMANDA KING
TargetedSENATE · HOUSE OF REPRESENTATIVES